Dna X (SONM) Depreciation & Amortization (CF) (2018 - 2025)

Dna X's Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $1.5 million for Q4 2025.

• Quarterly Depreciation & Amortization (CF) rose 63.68% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 13.05% YoY) and the FY2025 annual result came in at $4.3 million, up 20.89% from the prior year.
• Depreciation & Amortization (CF) was $1.5 million for Q4 2025 at Dna X, up from $952000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $1.8 million in Q4 2022 and bottomed at $67000.0 in Q3 2023.
• A 5-year average of $728350.0 and a median of $713500.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) tumbled 71.84% — and 2024, when it soared 1270.15%.
• Dna X's Depreciation & Amortization (CF) stood at $498000.0 in 2021, then jumped by 265.46% to $1.8 million in 2022, then plunged by 47.47% to $956000.0 in 2023, then retreated by 4.39% to $914000.0 in 2024, then jumped by 63.68% to $1.5 million in 2025.
• Business Quant data shows SONM's Depreciation & Amortization (CF) at $1.5 million in Q4 2025, $952000.0 in Q3 2025, and $797000.0 in Q2 2025.